What companies produce lab-grown meat sold in US stores?

1. What the question really asks and why it matters

The user is asking which companies produce lab-grown meat that consumers can buy off a supermarket shelf in the United States, a narrow query about physical retail availability rather than which startups exist or which firms hold regulatory approvals; distinguishing “approved to sell” from “actually in stores” is critical because approvals do not automatically mean retail presence ^[4][3].

2. The current retail reality: no cultivated meat on U.S. grocery shelves

Multiple news organizations and fact-checkers report that cultivated meat is not currently available for purchase in U.S. grocery stores or broadly in restaurants, despite the regulatory milestones of 2023; AP News and USA Today both explicitly state there are no products on store shelves yet and production volumes are currently limited to select restaurant offerings ^[1][4].

3. Which companies have U.S. regulatory clearance — and what that clearance actually allows

Two California companies, Upside Foods and GOOD Meat (the cultivated-meat arm tied to Eat Just), received U.S. regulatory clearances: the FDA completed pre-market consultations and USDA granted inspection approvals that allow those firms to produce and sell cultivated chicken under federal oversight — but those approvals have been applied to limited foodservice distribution, not mass retail placement ^[2][3].

4. Where those companies are selling now — restaurants and overseas markets

Following approvals, both Upside Foods and GOOD Meat have targeted high-end restaurants for initial offerings, and GOOD Meat has previously sold cultivated chicken in Singapore, the first country to authorize commercial sales; U.S. rollouts so far have been to a handful of restaurants rather than supermarkets ^[2][5][3].

5. Why grocery shelves remain empty: scale, cost and further approvals

Journalistic coverage emphasizes scaling limits, high production costs, and the logistical hurdles of moving from bioreactor batches to supermarket supply chains; even with regulatory green lights for chicken, companies must expand manufacturing capacity, drive down costs and satisfy distribution and labeling requirements before broad retail availability is feasible — observers predict years before meaningful grocery presence ^[6][3][7].

6. The wider company landscape — many players, few sellers in the U.S.

A growing roster of startups worldwide is developing cultivated or cultured meat, cataloged in industry lists and databases, but most remain in R&D or pilot production stages; comprehensive lists exist (e.g., industry trackers and Wikipedia compilations) showing the breadth of firms but not contradicting the fact that none are yet selling in U.S. supermarkets ^[8][9].

7. Contested terrain: politics, messaging and commercial incentives

The rollout of cultivated meat is politically charged — some U.S. states have moved to ban or restrict sales even as federal agencies approved products — and advocacy groups, investors, legacy agriculture interests and startups all have incentives to frame progress differently; reporting from AP, industry think tanks and NGOs highlights both optimism about sustainability and animal-welfare benefits and skepticism about timelines and claims ^[1][4][10].

8. Bottom line and what to watch next

As of the available reporting, no company is producing lab-grown meat that consumers can buy in U.S. grocery stores; Upside Foods and GOOD Meat hold the key federal approvals for cultivated chicken and have piloted restaurant sales and overseas commercial activity, but wider retail rollout depends on scale-up, pricing, supply-chain execution and political and state-level developments — continued monitoring of company production reports and regional retail pilots will reveal when that shifts ^[2][3][7].